Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 3
1(25.0%)
Phase 2
1(25.0%)
4Total
N/A(2)
Phase 3(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07326085Not ApplicableRecruiting

Pilot Study to Evaluate the Feasibility, Adherence and Acceptance of the MiDiálisis Platform for Patients on PD

Role: collaborator

NCT04952792Phase 2Completed

Study of Apixaban in Patients Receiving Hemodiafiltration

Role: collaborator

NCT03213756Not ApplicableCompleted

Isometric Preoperative Exercise on Autologous Arteriovenous Fistulas. Randomized Clinical Trial

Role: collaborator

NCT01955187Phase 3Completed

Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy

Role: collaborator

All 4 trials loaded